Form: 8-K

Current report filing

March 31, 2017

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC  20549

 

 

 

FORM 8-K

  

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 27, 2017

  

 

 

CRYOPORT, INC. 

(Exact name of registrant as specified in its charter)

 

Nevada   001-34632   88-0313393
(State of other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)
         
17305 Daimler St., Irvine CA 92614
(Address of Principal Executive Offices)
         
Registrant’s telephone number, including area code: (949) 470-2300
 
Not Applicable
(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14A-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

 

 

 

Item 8.01 Other Events.

 

On March 31, 2017, Cryoport, Inc. (the “Company”) completed an underwritten public offering (the “Offering”) of 6,325,000 shares of its common stock, par value $0.001 per share (the “Shares”). The Shares were issued and sold pursuant to an underwriting agreement (the “Underwriting Agreement”), dated March 28, 2017, by and among the Company and Cowen and Company, LLC and Needham & Company, LLC, as Representatives of the underwriters named in Schedule A thereto (collectively, the “Underwriters”), at a public offering price per share of $2.00. The Shares include 825,000 shares issued and sold pursuant to the Underwriters’ exercise in full of their option to purchase additional shares of common stock pursuant to the Underwriting Agreement. The Company will receive net proceeds of approximately $11.5 million from the Offering after deducting underwriting discounts and commissions and estimated offering expenses payable by the Company.

 

Certain of the Underwriters and their affiliates have provided in the past to the Company and its affiliates and may provide from time to time in the future certain commercial banking, financial advisory, investment banking and other services for the Company and such affiliates in the ordinary course of their business, for which they have received and may continue to receive customary fees and commissions.

 

The Offering was made pursuant to the Company’s effective registration statement on Form S-3 (Registration Statement No. 333-215776) previously filed with the Securities and Exchange Commission and a prospectus supplement. The foregoing is only a brief description of the terms of the Underwriting Agreement, does not purport to be a complete statement of the rights and obligations of the parties under the Underwriting Agreement and the transactions contemplated thereby, and is qualified in its entirety by reference to the Underwriting Agreement that is attached hereto as Exhibit 1.1. A copy of the opinion of Snell & Wilmer L.L.P. relating to the legality of the issuance and sale of the Shares is attached hereto as Exhibit 5.1.

 

On March 27, 2017, the Company issued a press release announcing the launch of the Offering. A copy of the Company’s press release is attached hereto as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference in its entirety.

 

On March 28, 2017, the Company issued a press release announcing the pricing of the Offering. A copy of the Company’s press release is attached hereto as Exhibit 99.2 to this Current Report on Form 8-K and is incorporated herein by reference in its entirety.

 

Item 9.01 Financial Statements and Exhibits

 

(d)           Exhibits.  The following material is filed as an exhibit to this Current Report on Form 8-K:

 

Exhibit    
Number Description                                                                   
     
1.1

Underwriting Agreement, dated March 28, 2017, by and among Cryoport, Inc. and Cowen and Company, LLC and Needham & Company, LLC, as representatives of the several underwriters named therein 

   
5.1

Opinion of Snell & Wilmer L.L.P.

   
23.1

Consent of Snell & Wilmer L.L.P. (included in Exhibit 5.1)

   
99.1

Press Release, dated March 27, 2017

   
99.2 Press Release, dated March 28, 2017

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

  

  CRYOPORT, INC.
   
   
   
Date: March 31, 2017 By:  /s/ Robert Stefanovich
    Robert Stefanovich
Chief Financial Officer

 

 

 

 

 

EXHIBIT INDEX

 

Exhibit    
Number Description                                                                   
     
1.1

Underwriting Agreement, dated March 28, 2017, by and among Cryoport, Inc. and Cowen and Company, LLC and Needham & Company, LLC, as representatives of the several underwriters named therein 

   
5.1

Opinion of Snell & Wilmer L.L.P.

   
23.1

Consent of Snell & Wilmer L.L.P. (included in Exhibit 5.1)

   
99.1

Press Release, dated March 27, 2017

   
99.2 Press Release, dated March 28, 2017